[1] 王志华, 初少莉, 陈绍行, 杜俭, 陆旭辉, 钱文琪, 吴顺娣, 郭冀珍, 朱鼎良, WANG Zhi-hua, CHU Shao-li, CHEN Shao-xing, DU Jian, LU Xu-hui, QIAN Wen-qi, WU Sun-di, GUO Ji-zhen, ZHU Ding-liang. 高血压住院患者病因及危险因素分析 [J]. 高血压杂志 2005.doi:10.3969/j.issn.1673-7245.2005.08.017
[2] 杨开初, 毛季萍. 原发性醛固酮增多症的分型、定侧诊断 [J]. 湖南医科大学学报 2001.doi:10.3321/j.issn:1672-7347.2001.04.033
[3] 吕朝晖, 郑蕾, 田慧, 陆菊明. 原发性醛固酮增多症高血压临床特点的研究 [J]. 解放军医学杂志 2003.doi:10.3321/j.issn:0577-7402.2003.05.016
[4] 全国血压抽样调查协作组. 中国各民族高血压患病情况调查 [J]. 1995.
[5] Masao Omura, Jun Saito, Kunio Yamaguchi. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan [J]. Hypertension Research 2004, 27(03).
[6] Conn Jw. Primay aldosteronism:a new clinical syndrome [J]. Journal of Laboratory and Clinical Medicine 1955, 45(01).
[7] Irong I, B iglieri EG. Primary A ldo steronism [M]. New York:Endocrine Hypertensio Raven Press L td 1990.
[8] Ferriss JB. Primary Hyperaldosteronism:Conn's syndrome and similar disorders [A]. New York:Elsevier Science Publishers, Biomedical Division 1992.
[9] Hiramatsu K, Yamada T, Yukimuta Y. A screening teat to identify aldosterone producing adenoma by measuring plasma rein activity.Results in hypertensive patients [J]. A reh Int Med 1981, 141(12).
[10] Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. [J]. Journal of human hypertension 2000.
[11] Stowasser M. Hyperaldosteronism primary versus tertiary [J]. Journal of Hypertension 2002, 20(12).
[12] Lim PO, Young WF, MacDonald TM. [J]. Journal of hypertension 2001.
[13] Gordon RD, Stowasser M, Tunny TJ. Hish incidence of primary aldosteronism in 199 patients referred with hypertension [J]. Clin Exp Pharmacol Physid 1994, 21(04).
[14] Norman M. Kaplan's clinical Hypertension [M]. 济南:山东科学技术出版社 2004. |
